Antithrombotic Drug Therapy for IgA Nephropathy: A Meta Analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Antithrombotic Drug Therapy for IgA Nephropathy: A Meta Analysis of Randomized Controlled Trials

Published:2011 Issue:21 Volume:50 Page:2503-2510
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Liu Xiu-Juan¹²,Geng Yan-Qiu²,Xin Shao-Nan³,Huang Guo-Ming¹,Tu Xiao-Wen¹,Ding Zhong-Ru¹,Chen Xiang-Mei²

Affiliation:

1. Division of Nephrology, 94 Hospital of Chinese PLA, PR China

2. Division of Nephrology, Kidney Institute and Key Lab of Chinese People's Liberation Army (PLA), General Hospital of Chinese PLA, Postgraduate Medical College of Chinese PLA, PR China

3. Nanchang Military Academy of Chinese PLA, PR China

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/50/21/50_21_2503/_pdf

Reference37 articles.

1. IgA Nephropathy

2. Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists

3. Immunomodulation with Low-Dose Immunoglobulins for Moderate IgA Nephropathy and Henoch-Schönlein Purpura

4. 4. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev 4: CD003965, 2003.

5. IgA Nephropathy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas;Journal of the American Society of Nephrology;2023-07-24

2. Circulating platelets supply ST6Gal-1 in patients with IgA nephropathy;Postgraduate Medicine;2022-12-26

3. Coagulation Potentials in Pediatric Patients with Immunoglobulin A Nephropathy;Pediatrics International;2021-10-26

4. The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation;Journal of Cellular and Molecular Medicine;2018-11-19

5. Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease;Oncotarget;2017-08-03